146 related articles for article (PubMed ID: 28956004)
1. Protease activity of legumain is inhibited by an increase of cystatin E/M in the DJ-1-knockout mouse spleen, cerebrum and heart.
Yamane T; Kozuka M; Yamamoto Y; Nakano Y; Nakagaki T; Ohkubo I; Ariga H
Biochem Biophys Rep; 2017 Mar; 9():187-192. PubMed ID: 28956004
[TBL] [Abstract][Full Text] [Related]
2. Expression and protease activity of mouse legumain are regulated by the oncogene/transcription co-activator, DJ-1 through p53 and cleavage of annexin A2 is increased in DJ-1-knockout cells.
Yamane T; Yamamoto Y; Nakano Y; Nakagaki T; Ohkubo I; Ariga H
Biochem Biophys Res Commun; 2015 Nov; 467(3):472-7. PubMed ID: 26462467
[TBL] [Abstract][Full Text] [Related]
3. Secretion of Legumain Increases in Conditioned Medium from DJ-1-Knockout Cells and in Serum from DJ-1-Knockout Mice.
Yamane T; Kato-Ose I; Sakamoto T; Nakano Y
Open Biochem J; 2018; 12():29-35. PubMed ID: 29541256
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of the legumain gene by p53 in HCT116 cells.
Yamane T; Murao S; Kato-Ose I; Kashima L; Yuguchi M; Kozuka M; Takeuchi K; Ogita H; Ohkubo I; Ariga H
Biochem Biophys Res Commun; 2013 Sep; 438(4):613-8. PubMed ID: 23942113
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of legumain inhibits cleavage of annexin A2 in the mouse kidney.
Yamane T; Hachisu R; Yuguchi M; Takeuchi K; Murao S; Yamamoto Y; Ogita H; Takasawa T; Ohkubo I; Ariga H
Biochem Biophys Res Commun; 2013 Jan; 430(2):482-7. PubMed ID: 23237799
[TBL] [Abstract][Full Text] [Related]
6. Intra- and extracellular regulation of activity and processing of legumain by cystatin E/M.
Smith R; Johansen HT; Nilsen H; Haugen MH; Pettersen SJ; Mælandsmo GM; Abrahamson M; Solberg R
Biochimie; 2012 Dec; 94(12):2590-9. PubMed ID: 22902879
[TBL] [Abstract][Full Text] [Related]
7. Glycosylation is important for legumain localization and processing to active forms but not for cystatin E/M inhibitory functions.
Lunde NN; Haugen MH; Bodin Larsen KB; Damgaard I; Pettersen SJ; Kasem R; Rut W; Drag M; Poreba M; Johansen HT; Solberg R
Biochimie; 2017 Aug; 139():27-37. PubMed ID: 28528272
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional Regulation of DJ-1.
Takahashi-Niki K; Niki T; Iguchi-Ariga SMM; Ariga H
Adv Exp Med Biol; 2017; 1037():89-95. PubMed ID: 29147905
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of a novel legumain-cleavable colchicine prodrug with cell-specific toxicity.
Smith RL; Åstrand OA; Nguyen LM; Elvestrand T; Hagelin G; Solberg R; Johansen HT; Rongved P
Bioorg Med Chem; 2014 Jul; 22(13):3309-15. PubMed ID: 24842619
[TBL] [Abstract][Full Text] [Related]
10. Legumain from bovine kidney: its purification, molecular cloning, immunohistochemical localization and degradation of annexin II and vitamin D-binding protein.
Yamane T; Takeuchi K; Yamamoto Y; Li YH; Fujiwara M; Nishi K; Takahashi S; Ohkubo I
Biochim Biophys Acta; 2002 Apr; 1596(1):108-20. PubMed ID: 11983426
[TBL] [Abstract][Full Text] [Related]
11. Ion Mobility-Based Enrichment-Free N-Terminomics Analysis Reveals Novel Legumain Substrates in Murine Spleen.
Ziegler AR; Dufour A; Scott NE; Edgington-Mitchell LE
Mol Cell Proteomics; 2024 Feb; 23(2):100714. PubMed ID: 38199506
[TBL] [Abstract][Full Text] [Related]
12. Evidence that unrestricted legumain activity is involved in disturbed epidermal cornification in cystatin M/E deficient mice.
Zeeuwen PL; van Vlijmen-Willems IM; Olthuis D; Johansen HT; Hitomi K; Hara-Nishimura I; Powers JC; James KE; op den Camp HJ; Lemmens R; Schalkwijk J
Hum Mol Genet; 2004 May; 13(10):1069-79. PubMed ID: 15044380
[TBL] [Abstract][Full Text] [Related]
13. Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells.
Morita Y; Araki H; Sugimoto T; Takeuchi K; Yamane T; Maeda T; Yamamoto Y; Nishi K; Asano M; Shirahama-Noda K; Nishimura M; Uzu T; Hara-Nishimura I; Koya D; Kashiwagi A; Ohkubo I
FEBS Lett; 2007 Apr; 581(7):1417-24. PubMed ID: 17350006
[TBL] [Abstract][Full Text] [Related]
14. Legumain, an asparaginyl endopeptidase, mediates the effect of M2 macrophages on attenuating renal interstitial fibrosis in obstructive nephropathy.
Wang D; Xiong M; Chen C; Du L; Liu Z; Shi Y; Zhang M; Gong J; Song X; Xiang R; Liu E; Tan X
Kidney Int; 2018 Jul; 94(1):91-101. PubMed ID: 29656902
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of legumain in plasma and plaques from patients with carotid atherosclerosis.
Lunde NN; Holm S; Dahl TB; Elyouncha I; Sporsheim B; Gregersen I; Abbas A; Skjelland M; Espevik T; Solberg R; Johansen HT; Halvorsen B
Atherosclerosis; 2017 Feb; 257():216-223. PubMed ID: 27940038
[TBL] [Abstract][Full Text] [Related]
16. Cystatin M/E (Cystatin 6): A Janus-Faced Cysteine Protease Inhibitor with Both Tumor-Suppressing and Tumor-Promoting Functions.
Lalmanach G; Kasabova-Arjomand M; Lecaille F; Saidi A
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919854
[TBL] [Abstract][Full Text] [Related]
17. MiRNA-3978 regulates peritoneal gastric cancer metastasis by targeting legumain.
Zhang Y; Wu YY; Jiang JN; Liu XS; Ji FJ; Fang XD
Oncotarget; 2016 Dec; 7(50):83223-83230. PubMed ID: 27793040
[TBL] [Abstract][Full Text] [Related]
18. Genetic mutations linked to Parkinson's disease differentially control nucleolar activity in pre-symptomatic mouse models.
Evsyukov V; Domanskyi A; Bierhoff H; Gispert S; Mustafa R; Schlaudraff F; Liss B; Parlato R
Dis Model Mech; 2017 May; 10(5):633-643. PubMed ID: 28360124
[TBL] [Abstract][Full Text] [Related]
19. Identification and functional characterization of legumain in amphioxus Branchiostoma belcheri.
Teng L; Wada H; Zhang S
Biosci Rep; 2009 Dec; 30(3):177-86. PubMed ID: 19552625
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
